WVE

Wave Life Sciences, Inc.

Healthcare · Biotechnology

$136.81 sample

-0.81 (-0.59%) 1D

Market cap

$301.3B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$136.81 +4.28% 3M daily closessample

139.66124.73

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider buy: General Counsel
Oct 02INSInsider sell: Chief Financial Officer
Sep 28INSInsider sell: 10% owner
Sep 17INSInsider sell: EVP, Operations
Sep 09INSInsider sell: Chief Executive Officer
Sep 01INSInsider sell: Chief Executive Officer
Aug 25INSInsider sell: Director
Aug 19INSInsider sell: Chief Financial Officer

Sign up to see the real WVE record →

Company facts

SEC EDGAR registration

Name: Wave Life Sciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -40sample, -100 to +100
Reporting currency: USD

Who is positioning in WVE

sample

Insiders: 17 insider transactions over 90 days, net selling, $659.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 19 funds hold $6.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.1B +17.1% y/y

Q4 2024Q3 2026

Inventory$5.7B +13.5% y/y

Q4 2024Q3 2026

Accounts receivable$4.5B +17.9% y/y

Q4 2024Q3 2026

Total debt$12.1B +10.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $168.0B +10.1% 3M
Sample peer B: $61.4B -9.4% 3M
Sample peer C: $297.9B -9.7% 3M
Sample peer D: $106.2B -1.4% 3M
Sample peer E: $273.6B -8.7% 3M